AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,925 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
AI stocks are navigating a choppy market, but marquee names remain firmly in focus for long-term growth. Here’s a tim...
A sharp selloff in optical interconnect makers hits Applied Optoelectronics as it plunges 13%, prompting questions ab...
Credo Technology Group is at the center of a renewed AI infrastructure rally, with a price prediction: from $269 surf...
NVIDIA CEO Jensen Huang told investors that AI-powered supercomputing could become a common feature in homes within y...
Sick of manually saving every month? The best savings apps for automation take the thinking out of saving, using roun...
European lawmakers are pushing for an ethics inquiry into FIFA chief Gianni Infantino after allegations that politica...
A former Central Colorado parcel near Salida is being developed into a 55-acre, 106-home 3D-printed community, testin...
In 2026, property owners are selling experiences, not just space. Lenders are adjusting terms as tenants sign leases ...
Tech stocks pulled back this week as margin risk reemerged amid a cooling chip cycle. Investors who bet on leverage w...
NVIDIA’s new alliance with Meta Platforms tightens the AI infrastructure backbone, pushing AMD to the back foot as in...
Apple is taking a guarded AI route, leaning on partnerships and modest capex. The strategy could alter AI investing d...